Ticlopidine

CAS: 55142-85-3
Molecular Formula: C14H14ClNS
Molecular Weight: 263.79
Product description:This drug in the body, the in vitro experimental results show that the seconds chlorine horse set to adenosine diphosphate (ADP) on the platelet aggregation induced by strong inhibition; It to collagen, thrombin, arachidonic acid, adrenaline and platelet aggregation induced by platelet activation factor and so on also has inhibitory effect, but not, strong or weak. In 24 to 48 hours after taking the drug began to present the antiplatelet effect; After 3 ~ 5 peak; The effect is still sustainable 72 hours after the drug was stopped. Unlike acetyl salicylic acid, its the first Ⅰ phase and the first Ⅱ phase aggregation induced by ADP has the inhibition; And there are certain depolymerization; It also inhibits the release of platelet response. In patients with ischemic heart disease, cerebrovascular disease, it also showed good antiplatelet effects.